Clinical Trial

Bio-Thera Solutions Announces First Patient Dosed in Phase 3 Clinical Trial for BAT8006, an Antibody Drug Conjugate Targeting Folate Receptor α for the Treatment of Platinum-Resistant Ovarian Cancer

GUANGZHOU, China, June 25, 2025 /PRNewswire/ - Bio-Thera Solutions Inc. (688177:SH), a commercial-stage biopharmaceutical company developing a pipeline of innovative therapies and…

6 months ago

Unbuzzd Launches $5 Million Reg D Capital Raise to Fund Growth and Path to Possible Initial Public Offering

Engages leading marketing firm MZ Digital and crowdfunding platform Dealmaker to successfully execute raise.Vancouver, British Columbia--(Newsfile Corp. - June 25,…

6 months ago

Unbuzzd Launches $5 Million Reg D Capital Raise to Fund Growth and Path to Possible Initial Public Offering

Engages leading marketing firm MZ Digital and crowdfunding platform Dealmaker to successfully execute raise.Vancouver, British Columbia--(Newsfile Corp. - June 25,…

6 months ago

Femasys Announces Historic Milestone with European Approval of FemBloc®, the First Non-Surgical Permanent Birth Control

--European CE mark approval of the entire FemBloc® system marks pivotal achievement in expanding safe, accessible and non-surgical permanent contraceptive…

6 months ago

Ernexa Therapeutics Expands Advisory Board to Form Integrated Scientific and Medical Advisory Board as it Prepares for Clinical Development

Addition of Dr. Amir Jazaeri and Dr. Anna Jonsson Reflects Ernexa’s Strategic Focus on Ovarian Cancer and Autoimmune Disease ProgramsCAMBRIDGE,…

6 months ago

Adial Pharmaceuticals Secures U.S.-Based Manufacturing Through Agreements with Cambrex and Thermo Fisher Scientific for Drug Substance and Drug Product Supply

Scope of Agreement with Cambrex to Provide Ondansetron HCL Drug Substance Under FDA Approved Drug Master File Scope Of Agreement…

6 months ago

Eyenovia Announces Co-Branded Validator with Kinetiq 

Kinetiq x Hyperion provides a premier liquid staking solution for institutional HYPE holdersLAGUNA HILLS, Calif., June 25, 2025 (GLOBE NEWSWIRE)…

6 months ago

Glucotrack and OneTwo Analytics Present Positive Final Results of First-In-Human Study for Continuous Blood Glucose Monitor at American Diabetes Association’s 85th Scientific Sessions

Comprehensive analysis confirms safety and strong accuracy of Glucotrack's innovative blood-based continuous glucose monitoring technology, with MARD of 7.7%RUTHERFORD, N.J.…

6 months ago